Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tony Johnson

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|January 13, 2012
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trialMarisa Hanney, Vee Prasher, Nicola Williams, et al.
Drug and Alcohol Dependence|January 16, 2022
Examining the impact of social distancing and methamphetamine use on sexual risk and intimate partner violence in sexual and gender minority young adults during the COVID-19 pandemicCasey D Xavier Hall, Marjan Javanbakht, Chitra Iyer, et al.
Lancet (London, England)|January 29, 2013
The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trialJo Howard, Moira Malfroy, Charlotte Llewelyn, et al.
Critical Care (London, England)|January 4, 2011
Reappraising the concept of massive transfusion in traumaSimon J Stanworth, Timothy P Morris, Christine Gaarder, et al.
BMC Psychiatry|August 31, 2010
The MATISSE study: a randomised trial of group art therapy for people with schizophreniaMike J Crawford, Helen Killaspy, Eleftheria Kalaitzaki, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 25, 2009
Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial)Clive Ballard, Richard Brown, Jane Fossey, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2020
Novel potent and selective pyrazolylpyrimidine-based SYK inhibitorsBernard Barlaam, Scott Boiko, Scott Boyd, et al.
The New England Journal of Medicine|October 5, 2007
Donepezil for the treatment of agitation in Alzheimer's diseaseRobert J Howard, Edmund Juszczak, Clive G Ballard, et al.
BMJ (Clinical Research Ed.)|March 1, 2012
Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trialMike J Crawford, Helen Killaspy, Thomas R E Barnes, et al.
Journal of Medicinal Chemistry|January 15, 2019
Tricyclic Indazoles-A Novel Class of Selective Estrogen Receptor Degrader AntagonistsJames S Scott, Andrew Bailey, David Buttar, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|January 13, 2012
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trialMarisa Hanney, Vee Prasher, Nicola Williams, et al.
Drug and Alcohol Dependence|January 16, 2022
Examining the impact of social distancing and methamphetamine use on sexual risk and intimate partner violence in sexual and gender minority young adults during the COVID-19 pandemicCasey D Xavier Hall, Marjan Javanbakht, Chitra Iyer, et al.
Lancet (London, England)|January 29, 2013
The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trialJo Howard, Moira Malfroy, Charlotte Llewelyn, et al.
Critical Care (London, England)|January 4, 2011
Reappraising the concept of massive transfusion in traumaSimon J Stanworth, Timothy P Morris, Christine Gaarder, et al.
BMC Psychiatry|August 31, 2010
The MATISSE study: a randomised trial of group art therapy for people with schizophreniaMike J Crawford, Helen Killaspy, Eleftheria Kalaitzaki, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 25, 2009
Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial)Clive Ballard, Richard Brown, Jane Fossey, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2020
Novel potent and selective pyrazolylpyrimidine-based SYK inhibitorsBernard Barlaam, Scott Boiko, Scott Boyd, et al.
The New England Journal of Medicine|October 5, 2007
Donepezil for the treatment of agitation in Alzheimer's diseaseRobert J Howard, Edmund Juszczak, Clive G Ballard, et al.
BMJ (Clinical Research Ed.)|March 1, 2012
Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trialMike J Crawford, Helen Killaspy, Thomas R E Barnes, et al.
Journal of Medicinal Chemistry|January 15, 2019
Tricyclic Indazoles-A Novel Class of Selective Estrogen Receptor Degrader AntagonistsJames S Scott, Andrew Bailey, David Buttar, et al.
Pageof 6